Perceptions of prostate cancer patients undergoing definitive radiotherapy on the impact of prostate cancer and radiation therapy on male sexuality

被引:0
|
作者
Daniels, Joseph [1 ]
Baffoe-Krapim, Leroy [1 ,2 ]
Nyantakyi, Andrew Yaw [1 ]
Ayabilah, Edwina Ayaaba [1 ]
Tackie, Judith Naa Odey [1 ]
Kyei, Kofi Adesi [1 ,2 ]
机构
[1] Korle Bu Teaching Hosp, Natl Radiotherapy Oncol & Nucl Med Ctr, Accra, Ghana
[2] Univ Ghana, Dept Radiog, Accra, Ghana
来源
ECANCERMEDICALSCIENCE | 2024年 / 18卷
关键词
radiotherapy; prostate cancer; erectile dysfunction; premature ejaculation; sexual function; QUALITY-OF-LIFE; ERECTILE DYSFUNCTION; MEN; SYMPTOMS; RISK;
D O I
10.3332/ecancer.2024.1726
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Male sexual function is an important aspect of the life of prostate cancer patients and plays a significant role in the long-term quality of life of prostate cancer survivors. However, there is a paucity of published literature on the perceived impact of prostate cancer and its treatment on the sexual function of patients in Ghana and West Africa in general. The purpose of this study was to explore the perceptions of prostate cancer patients on the effects of the disease and radiation therapy on male sexual function. The study also examined the changes in sexuality experienced by men with prostate cancer. Methods: This research was a descriptive longitudinal study conducted at the third largest hospital in Africa. The study included Ghanaian prostate cancer patients of all ages who were treated with definitive radiotherapy at the study site between October 2021 and May 2022. Quantitative data were collected and analysed using the Statistical Package for Social Sciences version 26.0 and Microsoft Excel 2019. Descriptive statistics were used to determine frequencies and percentages of the demographic characteristics. Results: The mean age of the participants was 65.7 years (SD 6.7) ranging from 50 to 81 years. Patients had different ideas about the potential adverse effects of prostate cancer (86%) and radiotherapy (70%) on male sexual function. A decrease in sexual desire (54%) was the commonest perceived effect of prostate cancer on male sexual function followed by premature ejaculation (49%) and a decrease in sexual activity (48%). On the other hand, erectile dysfunction (49%) was the commonest perceived effect of radiotherapy for prostate cancer on male sexual function followed by a decrease in sexual desire (38%) and premature ejaculation (37%). Health professionals were the major source of information regarding the perceptions of the patients on the effects of both prostate cancer (46%) and radiation therapy (43%) on male sexual function. Conclusion: There should be enhancement of awareness measures to educate Ghanaian cancer patients on the side effects and implications of treatment on their sexuality. Comprehensive sexual health assessment should be incorporated in the routine care of patients with cancers that have the potential to impact the sexual function of patients.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer
    A K Narang
    J Trieu
    N Radwan
    A Ram
    S P Robertson
    P He
    C Gergis
    E Griffith
    H Singh
    T A DeWeese
    S Honig
    A Annadanam
    S Greco
    C DeVille
    T McNutt
    T L DeWeese
    D Y Song
    P T Tran
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 203 - 209
  • [22] A bowel pathway for patients undergoing radiotherapy for prostate cancer
    Perna, C.
    Williamson, C.
    Khaksar, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S831 - S831
  • [23] DEFINITIVE RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER
    Bolla, M.
    Philippe, F.
    Camille, V.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S8 - S8
  • [24] End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer
    Narang, A. K.
    Trieu, J.
    Radwan, N.
    Ram, A.
    Robertson, S. P.
    He, P.
    Gergis, C.
    Griffith, E.
    Singh, H.
    DeWeese, T. A.
    Honig, S.
    Annadanam, A.
    Greco, S.
    DeVille, C.
    McNutt, T.
    DeWeese, T. L.
    Song, D. Y.
    Tran, P. T.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (02) : 203 - 209
  • [25] Internet use by patients with prostate cancer undergoing radiotherapy
    Smith, RP
    Devine, P
    Jones, H
    DeNittis, A
    Whittington, R
    Metz, JM
    UROLOGY, 2003, 62 (02) : 273 - 277
  • [26] The Fallacy of "Definitive Therapy" for Prostate Cancer
    Soloway, Mark S.
    Lokeshwar, Soum D.
    EUROPEAN UROLOGY, 2020, 78 (05) : 650 - 651
  • [27] Role of stereotactic radiotherapy in the management of patients with oligometastatic prostate cancer Stereotactic body radiation therapy for oligomastatic prostate cancer
    Bibault, Jean-Emmanuel
    BULLETIN DU CANCER, 2018, 105 (01) : 120 - 125
  • [28] Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing radiation treatment for prostate cancer
    Pisansky, TM
    UROLOGY, 2003, 62 (6B) : 36 - 45
  • [29] End of Treatment PSA as a Novel Prognostic Factor in Patients Undergoing Definitive Radiation for Prostate Cancer
    Narang, A.
    Ram, A. N.
    Robertson, S. P.
    He, P.
    Griffith, E.
    Singh, H.
    DeWeese, T.
    Honig, S.
    McNutt, T. R.
    Song, D.
    Tran, P. T.
    DeWeese, T. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S454 - S455
  • [30] Association between gut microbial change and acute gastrointestinal toxicity in patients with prostate cancer undergoing definitive radiation therapy
    Jang, Bum-Sup
    Lee, Dong Soo
    CANCER RESEARCH, 2024, 84 (06)